Author: admin

  • Fiona Bruce – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    Fiona Bruce – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    The below Parliamentary question was asked by Fiona Bruce on 2016-01-21.

    To ask the Secretary of State for Foreign and Commonwealth Affairs, if his Department will increase funding for human rights projects in North Korea.

    Mr Hugo Swire

    We currently deliver a range of projects in the DPRK through our bilateral project fund, many of which are intended to deliver improvements in human rights. We will be assessing future projects on human rights for the next year under the Magna Carta Fund for Human Rights and Democracy where we will consider the practicalities and implications of delivering human rights projects in DPRK and how to improve the appalling human rights situation. We will continue to support humanitarian work aimed at alleviating the plight of the most vulnerable in DPRK’s society.

  • Fiona Bruce – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    Fiona Bruce – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    The below Parliamentary question was asked by Fiona Bruce on 2016-01-21.

    To ask the Secretary of State for Foreign and Commonwealth Affairs, whether the UK has identified any people or ministries responsible for human rights violations in the Democratic People’s Republic of Korea.

    Mr Hugo Swire

    We have strongly supported the work of the UN Commission of Inquiry on Human Rights in the Democratic People’s Republic of Korea. The UN Commission of Inquiry documents serious human rights violations committed by the state in the DPRK and we have urged the DPRK authorities to respond in detail to the contents of the report. The report, which can be found at http://www.ohchr.org/EN/HRBodies/HRC/CoIDPRK/Pages/CommissionInquiryonHRinDPRK.aspx, includes details of human rights violations committed by officials from a number of state institutions and ministries. There must be no impunity for those accused of serious human rights violations.

  • Julie Cooper – 2016 Parliamentary Question to the Department of Health

    Julie Cooper – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Julie Cooper on 2016-01-21.

    To ask the Secretary of State for Health, what measures and regulations are in place to ensure that clinical drug tests are low-risk and safe.

    George Freeman

    Clinical trials of medicinal products in the United Kingdom are strictly regulated by European Union and UK legislation in order to ensure that the studies achieve their scientific targets while safeguarding the trial participants. Before any trial of a new medicine is initiated in humans, the medicinal product will have undergone extensive non-clinical testing, both in the laboratory and in animals as appropriate. The organisation responsible for proposing the trial (the Sponsor) will submit a Clinical Trial Authorisation application that will be reviewed by both the Medicines and Healthcare products Regulatory Agency (MHRA) and a research ethics committee.

    The MHRA assesses the safety and scientific value of the trial. A team of assessors will review the pharmaceutical quality of the medicinal product, the supporting data from pre-clinical testing and the details of the trial design and methodology, along with all available clinical data. The research ethics committee will ensure that the participant has been fully informed of all the necessary information about the trial, including information on potential risks and side effects.

    All Phase I trials in healthy volunteers are assessed taking into account European guidelines on strategies to identify and mitigate risks for first in human (FIH) trials. In the UK, trials that are identified as being higher risk are referred by the MHRA to an Expert Advisory Group of the Commission on Human Medicines for advice.

    The MHRA has instituted a Phase I accreditation scheme for organisations conducting phase I trials, in particular for those conducting FIH trials. MHRA Inspectors will grant Phase I accreditation only to those research units that exceed the basic regulatory Good Clinical Practice standards by having additional procedures that include the highest standards for avoiding harm to trial subjects and for handling any medical emergencies.

  • Glyn Davies – 2016 Parliamentary Question to the Department of Health

    Glyn Davies – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Glyn Davies on 2016-01-21.

    To ask the Secretary of State for Health, how many people were diagnosed with urinary incontinence in each of the last five years; and what the cost to the NHS was of treating that condition in each such year.

    Jane Ellison

    The Department does not hold information on the number of people admitted to hospital for a catheter-associated urinary tract infection, urinary tract infection or urinary incontinence.

    The following table shows a count of finished admission episodes (FAEs) in the last five years with a primary diagnosis of catheter-associated urinary tract infections.

    YEAR

    FAEs

    2010-11

    215

    2011-12

    294

    2012-13

    447

    2013-14

    641

    2014-15

    942

    The following table shows a count of FAEs in the last five years with a primary diagnosis of urinary incontinence in England.

    Year

    FAEs

    2010-11

    27,797

    2011-12

    26,751

    2012-13

    24,938

    2013-14

    23,498

    2014-15

    20,969

    The following table shows a count of FAEs in the last five years with a primary diagnosis of urinary tract infection in England

    YEAR

    FAEs

    2010-11

    168,581

    2011-12

    174,818

    2012-13

    184,924

    2013-14

    187,594

    2014-15

    195,282

    Source: Hospital episode statistics (HES), Health and social care information centre

    Notes:

    A finished admission episode (FAE) is the first period of admitted patient care under one consultant within one healthcare provider. FAEs are counted against the year or month in which the admission episode finishes. Admissions do not represent the number of patients, as a person may have more than one admission within the period.

    The primary diagnosis provides the main reason why the patient was admitted to hospital.

    The costs to the National Health Service of treating people with urinary tract infections and urinary incontinence is not available centrally.

    Such information as is available is from reference costs, which are the average unit costs of providing defined services to patients. Reference costs for acute care are published by Healthcare Resource Group (HRG), which are standard groupings of similar treatments that use similar resources. For example, costs relating to kidney or urinary tract interventions are assigned to the same HRGs.

    Table: Estimated total costs of kidney or urinary tract interventions and urinary incontinence or other urinary problems reported by NHS trusts and foundation trusts, 2010-11 to 2014-15 (£ millions)

    Kidney or urinary tract interventions

    Urinary incontinence or other urinary problems

    2010-11

    370.5

    28.2

    2011-12

    398.9

    28.1

    2012-13

    432.4

    27.8

    2013-14

    464.8

    28.3

    2014-15

    506.5

    27.6

    Source: Reference costs, Department of Health

  • Glyn Davies – 2016 Parliamentary Question to the Department of Health

    Glyn Davies – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Glyn Davies on 2016-01-21.

    To ask the Secretary of State for Health, how many people were diagnosed with urinary incontinence in each clinical commissioning group area in each of the last five years; and what the cost was of treating that condition in each such area in each such year.

    Jane Ellison

    The Department does not hold information on the number of people admitted to hospital for urinary incontinence.

    A count of finished admission episodes with a primary diagnosis of urinary incontinence, by clinical commissioning group of residence, 2010-11 to 2014-15 is provided in the attached table.

    The costs to the National Health Service of treating people with urinary tract infections and urinary incontinence is not available centrally.

    Such information as is available is from reference costs, which are the average unit costs of providing defined services to patients. Reference costs for acute care are published by Healthcare Resource Group (HRG), which are standard groupings of similar treatments that use similar resources. For example, costs relating to kidney or urinary tract interventions are assigned to the same HRGs.

    Table: Estimated total costs of kidney or urinary tract interventions and urinary incontinence or other urinary problems reported by NHS trusts and foundation trusts, 2010-11 to 2014-15 (£ millions)

    Kidney or urinary tract interventions

    Urinary incontinence or other urinary problems

    2010-11

    370.5

    28.2

    2011-12

    398.9

    28.1

    2012-13

    432.4

    27.8

    2013-14

    464.8

    28.3

    2014-15

    506.5

    27.6

    Source: Reference costs, Department of Health

  • Glyn Davies – 2016 Parliamentary Question to the Department of Health

    Glyn Davies – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Glyn Davies on 2016-01-21.

    To ask the Secretary of State for Health, how many people were admitted to hospital for falls and fractures associated with urinary incontinence in each of the last five years; and what the cost to the NHS was of treating people so admitted in each such year.

    Jane Ellison

    The Department does not hold information on the number of people admitted to hospital for falls and fractures associated with urinary incontinence and related costs.

  • Glyn Davies – 2016 Parliamentary Question to the Department of Health

    Glyn Davies – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Glyn Davies on 2016-01-21.

    To ask the Secretary of State for Health, how many people were admitted to hospital for urinary tract infections in each of the last five years; and what the cost to the NHS was of treating people so admitted in each such year.

    Jane Ellison

    The Department does not hold information on the number of people admitted to hospital for a catheter-associated urinary tract infection, urinary tract infection or urinary incontinence.

    The following table shows a count of finished admission episodes (FAEs) in the last five years with a primary diagnosis of catheter-associated urinary tract infections.

    YEAR

    FAEs

    2010-11

    215

    2011-12

    294

    2012-13

    447

    2013-14

    641

    2014-15

    942

    The following table shows a count of FAEs in the last five years with a primary diagnosis of urinary incontinence in England.

    Year

    FAEs

    2010-11

    27,797

    2011-12

    26,751

    2012-13

    24,938

    2013-14

    23,498

    2014-15

    20,969

    The following table shows a count of FAEs in the last five years with a primary diagnosis of urinary tract infection in England

    YEAR

    FAEs

    2010-11

    168,581

    2011-12

    174,818

    2012-13

    184,924

    2013-14

    187,594

    2014-15

    195,282

    Source: Hospital episode statistics (HES), Health and social care information centre

    Notes:

    A finished admission episode (FAE) is the first period of admitted patient care under one consultant within one healthcare provider. FAEs are counted against the year or month in which the admission episode finishes. Admissions do not represent the number of patients, as a person may have more than one admission within the period.

    The primary diagnosis provides the main reason why the patient was admitted to hospital.

    The costs to the National Health Service of treating people with urinary tract infections and urinary incontinence is not available centrally.

    Such information as is available is from reference costs, which are the average unit costs of providing defined services to patients. Reference costs for acute care are published by Healthcare Resource Group (HRG), which are standard groupings of similar treatments that use similar resources. For example, costs relating to kidney or urinary tract interventions are assigned to the same HRGs.

    Table: Estimated total costs of kidney or urinary tract interventions and urinary incontinence or other urinary problems reported by NHS trusts and foundation trusts, 2010-11 to 2014-15 (£ millions)

    Kidney or urinary tract interventions

    Urinary incontinence or other urinary problems

    2010-11

    370.5

    28.2

    2011-12

    398.9

    28.1

    2012-13

    432.4

    27.8

    2013-14

    464.8

    28.3

    2014-15

    506.5

    27.6

    Source: Reference costs, Department of Health

  • David Burrowes – 2016 Parliamentary Question to the Department of Health

    David Burrowes – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by David Burrowes on 2016-01-21.

    To ask the Secretary of State for Health, what progress is being made on conducting antenatal mental health assessments.

    Alistair Burt

    Our commitment to improving perinatal mental health was demonstrated by the Prime Minister’s recent announcement of a £290 million investment over the next five years to 2020/21 in perinatal mental health services. This builds on the initial investment of £75 million announced in the March 2015 Budget, making a total investment from 2015/16 to 2020/21 of £365million.

    The National Institute for Health Care and Excellence guidelines recommend that during a pregnant women’s first contact with primary care or when booking her first appointment she should be asked how she is feeling. This will enable a sensitive conversation and, if appropriate, for a referral to her general practitioner for further assessment or, if a severe mental health problem is suspected, to a mental health professional.

    It has been recognised that more information is needed about perinatal mental health. The Health and Social Care Information Centre is working on the implementation of a new Mental Health Services Dataset which will seek to increase the amount of data available about antenatal mental health assessments. We expect that some initial data on perinatal mental health will be available later this year. We will use this initial information to refine how data on perinatal mental health is collected going forward.

  • Luciana Berger – 2016 Parliamentary Question to the Department of Health

    Luciana Berger – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Luciana Berger on 2016-01-21.

    To ask the Secretary of State for Health, how much has been spent on treatment for drug and alcohol addiction in (a) each year since 2010 and (b) each month of 2015.

    Jane Ellison

    I refer the hon. Member to the answer I gave on 14 January 2016 to Question 21900.

    It is not possible to provide a breakdown of monthly spend on treatment for drug and alcohol addiction due to disproportionate cost.

    “

  • Glyn Davies – 2016 Parliamentary Question to the Department of Health

    Glyn Davies – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Glyn Davies on 2016-01-21.

    To ask the Secretary of State for Health, how many people were admitted to hospital for catheter-associated urinary tract infections in each of the last five years; and what the cost was of treating those people.

    Jane Ellison

    The Department does not hold information on the number of people admitted to hospital for a catheter-associated urinary tract infection, urinary tract infection or urinary incontinence.

    The following table shows a count of finished admission episodes (FAEs) in the last five years with a primary diagnosis of catheter-associated urinary tract infections.

    YEAR

    FAEs

    2010-11

    215

    2011-12

    294

    2012-13

    447

    2013-14

    641

    2014-15

    942

    The following table shows a count of FAEs in the last five years with a primary diagnosis of urinary incontinence in England.

    Year

    FAEs

    2010-11

    27,797

    2011-12

    26,751

    2012-13

    24,938

    2013-14

    23,498

    2014-15

    20,969

    The following table shows a count of FAEs in the last five years with a primary diagnosis of urinary tract infection in England

    YEAR

    FAEs

    2010-11

    168,581

    2011-12

    174,818

    2012-13

    184,924

    2013-14

    187,594

    2014-15

    195,282

    Source: Hospital episode statistics (HES), Health and social care information centre

    Notes:

    A finished admission episode (FAE) is the first period of admitted patient care under one consultant within one healthcare provider. FAEs are counted against the year or month in which the admission episode finishes. Admissions do not represent the number of patients, as a person may have more than one admission within the period.

    The primary diagnosis provides the main reason why the patient was admitted to hospital.

    The costs to the National Health Service of treating people with urinary tract infections and urinary incontinence is not available centrally.

    Such information as is available is from reference costs, which are the average unit costs of providing defined services to patients. Reference costs for acute care are published by Healthcare Resource Group (HRG), which are standard groupings of similar treatments that use similar resources. For example, costs relating to kidney or urinary tract interventions are assigned to the same HRGs.

    Table: Estimated total costs of kidney or urinary tract interventions and urinary incontinence or other urinary problems reported by NHS trusts and foundation trusts, 2010-11 to 2014-15 (£ millions)

    Kidney or urinary tract interventions

    Urinary incontinence or other urinary problems

    2010-11

    370.5

    28.2

    2011-12

    398.9

    28.1

    2012-13

    432.4

    27.8

    2013-14

    464.8

    28.3

    2014-15

    506.5

    27.6

    Source: Reference costs, Department of Health